Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Xlife Sciences AG
XLSCurrent price
27.5 CHF
-0.5 CHF (-1.79%)
Last closed
27.5 CHF
Company
www.xlifesciences.ch
ISIN
CH0461929603
Sector
Healthcare
Industry
Biotechnology
Exchange
SIX Swiss Exchange
Capitalization
145 060 509 CHF
Yield for 12 month
-31.08 %
1Y
3Y
5Y
10Y
15Y
XLS
Xlife Sciences AG focuses on the development and commercialization of technologies in the life sciences sector. The company's project consists of technology platforms that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data. It also engages in developing mono-and bispecific anti-tumor antibodies for the treatment of life-threatening diseases; researching, developing, and manufacturing chemical and active pharmaceutical ingredients for human and veterinary medicines; and early identification kidney diseases. Xlife Sciences AG also focuses on functional screening of antibodies by microfluidics-based technologies; and offers Neuromex, a screening instrument for the early-stage detection of neurodegenerative diseases. Xlife Sciences AG was founded in 2019 and is based in Zurich, Switzerland. Address: Talacker 35, Zurich, Switzerland, 8001
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
58.91 CHFP/E ratio
7.6687Dividend Yield
–Current Year
+998 911 CHF
Last Year
+1 038 865 CHF
Current Quarter
+351 668 CHF
Last Quarter
+662 467 CHF
Current Year
+453 779 CHF
Last Year
+187 608 CHF
Current Quarter
+124 658 CHF
Last Quarter
+181 352 CHF
Key Figures XLS
1 year
3 years
5 years
10 years
EBITDA
-2 772 499 CHF
Operating Margin TTM
PE Ratio
7.6687
Return On Assets TTM
-2.36 %
PEG Ratio
–
Return On Equity TTM
4.47 %
Wall Street Target Price
58.91 CHF
Revenue TTM
1 000 769 CHF
Book Value
48.34 CHF
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
0.5 %
Dividend Yield
–
Gross Profit TTM
362 926 CHF
Earnings per share
3.29 CHF
Diluted Eps TTM
3.29 CHF
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
-3.7 %
Profit Margin
2144.5 %
Dividend Analytics XLS
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History XLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation XLS
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
7.6687
Forward PE
–
Enterprise Value Revenue
200.6662
Price Sales TTM
144.949
Enterprise Value EBITDA
7.2901
Price Book MRQ
0.5261
Financials XLS
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators XLS
For 52 weeks
24.15 CHF
51.94 CHF
50 Day MA
29.95 CHF
Shares Short Prior Month
–
200 Day MA
37.03 CHF
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart